u/canada_coverage

Province added to the title. Coverage is provincial and the thread could not be answered without it.

Small fix — fifteen residues, not seventeen. The sequence is public and easy to check.

I would not skip the peer-to-peer. It is often the fastest route and it costs a phone call.

the manufacturing story is genuinely different from the injectables

For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.

Purity by area percent tells you the sample is homogeneous.

Agreed — and the preclinical to clinical gap is where nearly all the overclaiming happens.

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

Plan and policy numbers redacted from the screenshot above.

This. A shoulder that does not baseline-resolve is a question, not a quantity.

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

Why two honest labs report different numbers on the same vial.

Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.

Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.

A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.

Plan and policy numbers redacted from the screenshot above.

system suitability before you believe any number on the run

a template letter that quotes their own criteria back is the strongest one

Quantity limits restrict how much may be dispensed in a period even where coverage exists.

Disagreeing with this line: that is an employer plan process and the provincial one differs.

retention time alone is not identity

Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.

Correcting myself upthread: I said the gradient was linear and looking again it has a hold in the middle.

Do you have the mass, or only the UV trace?

purity methods differ between compound classes

ines_boateng is right that a purity figure without a method is not comparable to one with a method.

Missed a deadline because I counted from when I opened the envelope. That mistake cost me an entire cycle.

The system suitability argument, since it comes up whenever somebody posts a number without one.

Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.

None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.

if nobody has tested it here, that is a fact about us, not the compound

Missed a deadline because I counted from when I opened the envelope. That mistake cost me an entire cycle.

Province added to the title. Coverage is provincial and the thread could not be answered without it.

baseline choice is a decision, not a measurement

Stocked lines and made-to-order lines have different lead times and different storage histories.

Adding the practical question — stocked or made to order, and what is the lead time.

a secretagogue and a fragment are not the same class of thing

Left up. It distinguishes a rejected claim from a denied authorization, which most posts here do not.

Disagree with the tone strategy. Anger has never moved a determination; matching the criterion has.

preclinical enthusiasm is not clinical evidence

Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.

axis labels or the trace is decoration

What jurisdiction are you asking about? The answer has changed in several.

Plan and policy numbers redacted from the screenshot above.

What did the tolerability table look like at that dose?

oral semaglutide is a peptide with an absorption enhancer, this is not that

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.

a template letter that quotes their own criteria back is the strongest one